The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide
Official Title: A Multicenter, Multiple-dose, Single-arm Study to Switch Hemodialysis Subjects With Secondary Hyperparathyroidism From Oral Cinacalcet HCl to Intravenous AMG 416
Study ID: NCT01932970
Brief Summary: This is a multicenter, multiple-dose, single-arm, open-label study to assess the impact on serum corrected calcium levels when switching patients from cinacalcet to etelcalcetide (AMG 416).
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Research Site, Alhambra, California, United States
Research Site, Azusa, California, United States
Research Site, Bakersfield, California, United States
Research Site, Chula Vista, California, United States
Research Site, La Mesa, California, United States
Research Site, Los Angeles, California, United States
Research Site, Lynwood, California, United States
Research Site, Riverside, California, United States
Research Site, Whittier, California, United States
Research Site, Arvada, Colorado, United States
Research Site, North Haven, Connecticut, United States
Research Site, Coral Springs, Florida, United States
Research Site, Hollywood, Florida, United States
Research Site, Miami, Florida, United States
Research Site, Pembroke Pines, Florida, United States
Research Site, Pinecrest, Florida, United States
Research Site, Tampa, Florida, United States
Research Site, Augusta, Georgia, United States
Research Site, Evergreen Park, Illinois, United States
Research Site, Michigan City, Indiana, United States
Research Site, Baton Rouge, Louisiana, United States
Research Site, Lafayette, Louisiana, United States
Research Site, Columbus, Mississippi, United States
Research Site, Gulfport, Mississippi, United States
Research Site, Farmington, Missouri, United States
Research Site, Kansas City, Missouri, United States
Research Site, Saint Louis, Missouri, United States
Research Site, Portsmouth, New Hampshire, United States
Research Site, Eatontown, New Jersey, United States
Research Site, College Point, New York, United States
Research Site, Oklahoma City, Oklahoma, United States
Research Site, Philadelphia, Pennsylvania, United States
Research Site, Orangeburg, South Carolina, United States
Research Site, Arlington, Texas, United States
Research Site, Greenville, Texas, United States
Research Site, Houston, Texas, United States
Research Site, McAllen, Texas, United States
Research Site, San Antonio, Texas, United States
Research Site, Fairfax, Virginia, United States
Research Site, Hampton, Virginia, United States
Name: MD
Affiliation: Amgen
Role: STUDY_DIRECTOR